Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi Balance Sheet Health
Financial Health criteria checks 5/6
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi has a total shareholder equity of TRY2.1B and total debt of TRY54.0M, which brings its debt-to-equity ratio to 2.6%. Its total assets and total liabilities are TRY2.6B and TRY547.0M respectively. Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi's EBIT is TRY181.6M making its interest coverage ratio 4.3. It has cash and short-term investments of TRY402.1M.
Key information
2.6%
Debt to equity ratio
₺53.97m
Debt
| Interest coverage ratio | 4.3x |
| Cash | ₺402.06m |
| Equity | ₺2.08b |
| Total liabilities | ₺546.99m |
| Total assets | ₺2.63b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MEDTR's short term assets (TRY1.5B) exceed its short term liabilities (TRY403.4M).
Long Term Liabilities: MEDTR's short term assets (TRY1.5B) exceed its long term liabilities (TRY143.6M).
Debt to Equity History and Analysis
Debt Level: MEDTR has more cash than its total debt.
Reducing Debt: Insufficient data to determine if MEDTR's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: MEDTR's debt is well covered by operating cash flow (823.7%).
Interest Coverage: MEDTR's interest payments on its debt are well covered by EBIT (4.3x coverage).